Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Treasury Shares: 2019

Historic Treasury Shares for Keros Therapeutics (KROS) over the last 1 years, with Dec 2019 value amounting to $34,557.

  • Keros Therapeutics' Treasury Shares was N/A to $721,700 in Q3 2025 from the same period last year, while for Sep 2025 it was $721,700, marking a year-over-year change of. This contributed to the annual value of $34,557 for FY2019, which is N/A change from last year.
  • Keros Therapeutics' Treasury Shares amounted to $34,557 in FY2019.
  • Keros Therapeutics' 5-year Treasury Shares high stood at $34,557 for FY2019, and its period low was $34,557 during FY2019.
  • Over the past 1 years, Keros Therapeutics' median Treasury Shares value was $34,557 (recorded in 2019), while the average stood at $34,557.